Core Viewpoint - WuXi AppTec (02268.HK) has announced a placement agreement with Morgan Stanley to issue up to 22.277 million shares at a price of HKD 58.85 per share, representing a discount of approximately 4.00% from the last closing price of HKD 61.30 [1] Group 1: Placement Details - The maximum number of shares to be placed represents approximately 1.85% of the existing issued share capital and about 1.82% of the enlarged issued share capital after the placement [1] - The total expected proceeds from the placement will be approximately HKD 1.311 billion (around USD 168 million), with net proceeds estimated at about HKD 1.301 billion (around USD 167 million) [1] Group 2: Use of Proceeds - Approximately 90% of the net proceeds will be used to further expand the group's service capabilities and production capacity, including clinical and commercial production capacity for bioconjugates, active pharmaceutical ingredients, and products [1] - About 10% of the net proceeds will be allocated for the group's working capital needs and general corporate purposes [1]

近期，国药集团先后宣布收购血液制品行业的领军企业派林生物和药用玻璃行业龙头企业山东药玻，成 为医药行业并购的典型案例。 （文章来源：中国证券报） 国务院国资委9月2日消息，8月27日至30日，国务院国资委与中国科学院联合举办中央企业生物科技产 业高级研修班。国务院国资委副主任谭作钧表示，要围绕服务健康中国建设，加快发展中央企业生物医 药产业，坚持创新驱动发展、长周期发展、差异化发展，通过深度学习、思想碰撞、头脑风暴，更加清 晰研判生物医药产业发展大势，更加精准把握中央企业发展重点方向及实施路径，更加积极推动与中国 科学院院所的产学研用协同创新，加快打造生物医药领域的国家队，推动我国生物医药产业高质量发 展。 今年3月，国务院国资委党委在《民主与法制》周刊发表署名文章称，对于生物医药等产业基础比较薄 弱的领域，鼓励国有企业运用并购重组、股权投资、产业基金等多种方式，加快形成产业影响力。 ...

Core Viewpoint - The article highlights the historical significance of the Tan Kou ferry site in Hainan, where the first shot of the Qiongya Anti-Japanese War was fired, and contrasts this with the current development of Haikou as a hub for high-quality economic growth and innovation under the Free Trade Port policy [1] Group 1: Historical Context - The Tan Kou ferry site is a significant historical location where the Qiongya Anti-Japanese Independent Team fired the first shot against Japanese forces on February 10, 1939 [1] - The site played a crucial role in blocking Japanese advances and protecting local populations during the war [1] Group 2: Current Economic Development - Haikou is leveraging its Free Trade Port policy to focus on new industries such as integrated circuits, biomedicine, new energy vehicles, biodegradable materials, digital economy, and intelligent manufacturing [1] - The "Lecang Research + Haikou Production" model for international innovative drugs has been established, creating a closed-loop system for high-quality development [1] - Haikou is also hosting a series of international events and performances, aiming to become a "New Year City" and "City of Performing Arts," with the number of international friendship cities increasing to 47 [1] Group 3: Future Prospects - The article emphasizes that Hainan's historical significance is being transformed into a modern economic powerhouse, with a strong focus on high-quality development and innovation [1]

近日，中国上市公司协会（简称"中上协"）发布的数据显示，今年上半年，全市场上市公司实现营业收 入35.01万亿元，同比增长0.16%。值得注意的是，同期，全市场的研发投入为7456.87亿元，同比增长 2.68%。 而我们把视角切换到市场上来看，资本市场作为经济的晴雨表，其反应最为敏锐。一个值得关注的现象 是，投资者的估值模型也正在悄然迭代。传统的市盈率（PE）估值体系在评估许多高研发投入的科技 型企业时，开始显得力不从心。投资者们正逐渐学会"看懂"研发投入的长期价值，愿意为那些暂时牺牲 短期利润以换取未来技术领先地位和广阔市场空间的企业，给予更高的估值溢价。这其实也是一种价值 发现的进化。投资者不再仅仅关注企业"现在能赚多少钱"，而是更加关心"未来能创造多大价值"。研发 强度、专利数量、技术路线的先进性以及在全球产业链中的卡位，正成为比短期盈利波动更为重要的价 值标尺。 这种从"看现在"到"看未来"的视角转变，为那些坚持长期主义、深耕技术的企业提供了宝贵的资本支 持，形成了一个鼓励创新的正向循环。 当然，要想实现从研发投入到商业成功，中间依然隔着巨大的不确定性，这既是科技创新的魅力所在， 也是其风险所在。高 ...

Core Viewpoint - The Hong Kong stock market is experiencing increased trading activity and stability, supported by significant inflows of southbound capital, which have reached a historical high of over 1 trillion HKD in net inflows this year [1][3]. Group 1: Southbound Capital Inflows - As of September 2, 2023, the cumulative net inflow of southbound capital has surpassed 1 trillion HKD, reaching 10,002.21 million HKD, marking a record high [1]. - Daily trading volume of southbound capital has increased from approximately 5% at the beginning of the Stock Connect program to around 35% currently, enhancing liquidity in the Hong Kong market [1]. - Since the launch of the Stock Connect in November 2014, total southbound capital inflows have reached 4.7 trillion HKD, with a consistent net inflow trend observed since 2015 [3][4]. Group 2: Investment Preferences - The top ten stocks with the largest increase in market value held by southbound capital include Tencent Holdings, Alibaba, and others, with Tencent seeing an increase of 2,169.2 million HKD [2]. - Southbound capital is primarily focused on internet companies with global competitiveness, stable cash flow, high dividend-paying value stocks, and innovative biopharmaceutical companies [2]. - The preference for high-dividend assets has led to significant valuation improvements in sectors such as finance, energy, and telecommunications over the past two years [2]. Group 3: Market Dynamics and Future Outlook - The influx of southbound capital has transformed the investment landscape of the Hong Kong market, making it a core market for global investors seeking Chinese assets [5]. - Analysts predict that southbound capital will continue to flow into the Hong Kong market, driven by a combination of valuation recovery and improved profit expectations [5][6]. - The shift from retail to institutional investors in southbound capital has enhanced the professional investment capabilities and value discovery functions within the market [6].

Group 1 - The core focus of the Sci-Tech Innovation Board is on "hard technology" to accelerate innovation and support national technological self-reliance [1] - Eight leading companies from Hunan's Sci-Tech Innovation Board showcased their achievements, including Iron Construction Heavy Industry, Times Electric, Aerospace Hanyu, and others, representing key sectors such as tunneling, rail transit, aerospace, and biomedicine [1][2] - The performance briefing was organized by the Shanghai Stock Exchange in collaboration with various local financial authorities, aiming to enhance communication between listed companies and investors [1][5] Group 2 - Iron Construction Heavy Industry reported a new contract value of 7.727 billion yuan in the first half of 2025, a year-on-year increase of 3.15%, with significant contributions from tunneling machinery and rail transit equipment [2] - Times Electric focuses on a "diversified" strategy in the rail transit sector, developing a complete technology and industry chain from chips to complete systems [2] - Jin Tian Titanium Industry is engaged in the R&D and production of high-end titanium and titanium alloy materials, with applications in aerospace and naval equipment [2][4] Group 3 - Aerospace Hanyu is seizing opportunities in satellite internet, aiming to expand its product offerings in response to growing market demands [4] - Weisheng Information is integrating AI technology into its products, achieving a revenue of 642 million yuan in the first half of the year, accounting for 47% of total revenue [4] - The Hunan Xiangjiang New Area is actively promoting the development of listed companies and enhancing investor confidence through initiatives like the establishment of the Sci-Tech Innovation Board Cultivation Center [5][6] Group 4 - The Xiangjiang New Area has 57 listed companies, with 9 of them on the Sci-Tech Innovation Board, representing over half of Hunan's total [6] - Saint湘生物 has initiated a corporate venture capital fund to invest in nearly 30 medical projects, focusing on integrating AI with healthcare [6] - The Hunan provincial government is committed to supporting hard technology enterprises and enhancing their core competitiveness through increased R&D investment [7]

江苏浩欧博生物医药股份有限公司 第三届监事会第二十次会议决议公告 证券代码：688656 证券简称：浩欧博 公告编号：2025-051 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 （公 告编号：2025-052）。 一、监事会会议召开情况 特此公告。 江苏浩欧博生物医药股份有限公司 监事会 江苏浩欧博生物医药股份有限公司（以下简称"公司"）第三届监事会第二 十次会议于 2025 年 9 月 1 日以邮件形式发出通知，并于 2025 年 9 月 2 日下午 13:00 在公司会议室召开。经与会监事一致同意，豁免本次会议通知期限。本次会议应 出席监事 3 名，实际出席监事 3 名，会议由公司监事会主席焦海云女士主持。会 议的召集、召开程序符合《中华人民共和国公司法》《公司章程》等有关规定。 二、监事会会议审议情况 经审议，监事会认为：公司募投项目"新建体外诊断试剂研发中心项目"的 结项符合实际情况。该事项的审议和决策程序符合《上市公司募集资金监管规则》 《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等相 ...

Group 1 - The company held the first bondholders' meeting for the "Garden Convertible Bonds" on September 2, 2025, in accordance with relevant regulations and rules [1][2] - A total of 2 bondholders attended the meeting in person, representing 11,031 bonds with an outstanding principal amount of 1,103,100 yuan, which accounts for 0.09% of the total outstanding bond face value [2] - The meeting adopted a combination of on-site voting and communication voting, with the results indicating that all attending bondholders agreed to the proposals presented [2] Group 2 - The legal opinions provided by Beijing Haotian Law Firm confirmed that the meeting's convening and procedures complied with relevant laws and regulations, and the qualifications of the conveners and attendees were valid [2] - The meeting's voting procedures and results were deemed legal and valid according to the legal opinions [2] - The company will keep the legal opinion document available for review [2]

Group 1 - Hubei Province's high-tech enterprises have increased by 2.9 times since the beginning of the 14th Five-Year Plan, with projections to exceed 30,000 by 2024, ranking first in Central China [1] - The province's focus on emerging industries, represented by "light, chip, screen, terminal, and network," is seen as a new competitive advantage, with key clusters continuously developing [1] - By 2024, three major industries in Hubei—optoelectronics information, automotive manufacturing and services, and health—are expected to surpass 1 trillion yuan in scale, while several advantageous industries will exceed 500 billion yuan [1] Group 2 - The biopharmaceutical manufacturing revenue in Hubei is projected to reach 123.5 billion yuan in 2024, reflecting a year-on-year growth of 3.5% [1] - China Information Communication Technology Group is focusing on AI and computing infrastructure opportunities, aiming to enhance development scale and strengthen collaboration with leading enterprises in Hubei [2] - Hubei will continue to increase support for strategic emerging industries, emphasizing the construction of innovation platforms led by national laboratories and research institutions [2]

登录新浪财经APP 搜索【信披】查看更多考评等级 百普赛斯于2024年8月29日召开第二届董事会第八次会议，同年9月20日召开2024年第一次临时股东大 会，审议通过《关于回购公司股份方案的议案》。公司决定使用自有资金，以集中竞价交易方式回购部 分已发行的人民币普通股股份，用于注销并减少公司注册资本。 此次回购资金总额设定在2000万元（含）至4000万元（含）之间，回购价格上限为50.00元/股（含）， 回购实施期限为自股东大会审议通过方案之日起12个月内。相关公告于2024年8月30日、9月20日在巨潮 资讯网披露。 2025年6月24日，公司第二届董事会第十九次会议审议通过《关于调整回购股份价格上限的议案》，将 回购价格上限提升至80.00元/股（含），该调整自当日生效。2024年年度权益分派实施后，因相关规 定，自2025年7月11日除权除息日起，回购股份价格上限调整为56.91元/股（含）。 截至2025年8月31日，公司通过股份回购专用证券账户，以集中竞价交易方式回购股份40.01万股，占公 司总股本的0.33%，最高成交价为50.00元/股，最低成交价为49.98元/股，支付的总金额为1999. ...